- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 239/48 - Deux atomes d'azote
Détention brevets de la classe C07D 239/48
Brevets de cette classe: 1136
Historique des publications depuis 10 ans
|
106
|
100
|
78
|
85
|
65
|
78
|
50
|
60
|
31
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Rigel Pharmaceuticals, Inc. | 540 |
36 |
| Bristol-myers Squibb Company | 4892 |
35 |
| Signal Pharmaceuticals, LLC | 180 |
35 |
| Boehringer Ingelheim International GmbH | 4704 |
24 |
| Novartis AG | 10904 |
21 |
| Janssen Sciences Ireland UC | 183 |
21 |
| Merck Patent GmbH | 5850 |
16 |
| Korea Research Institute of Chemical Technology | 1376 |
15 |
| Alexion Pharmaceuticals, Inc. | 633 |
14 |
| Afferent Pharmaceuticals, Inc. | 25 |
13 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 932 |
13 |
| F. Hoffmann-La Roche AG | 7926 |
12 |
| FUJIFILM Corporation | 29228 |
12 |
| Celgene Avilomics Research, Inc. | 31 |
12 |
| Dana-Farber Cancer Institute, Inc. | 2553 |
12 |
| Takeda Pharmaceutical Company Limited | 2704 |
11 |
| Astellas Pharma Inc. | 1086 |
11 |
| Portola Pharmaceuticals, Inc. | 88 |
11 |
| Genentech, Inc. | 3961 |
10 |
| Bayer Cropscience AG | 2062 |
10 |
| Autres propriétaires | 792 |